Penumbra, Inc. Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 8 of 8 Posts
Bull Of The Day: Penumbra (PEN)
Article By: Kevin Cook Tuesday, September 25, 2018 2:30 PM EDT
Penumbra made a strong swing to sustainable profitability this year on the back of projected 27.5% sales growth from last year's $333 million to over $425 million in revenue.
In this article: PEN Also: ABT, BAX, EW, JNJ, MDT, SYK, IART, AXGN, MZOR
Read
Brave Market Volatility With These 5 Low-Beta Stocks
Article By: Zacks Investment Research Friday, September 21, 2018 3:25 AM EDT
It is a common misconception that only risky investments prove rewarding. The strategy works best when the market is bullish.
In this article: HCA, NOA, ECOL, GIII, PEN
Read
Medical Product Stocks Tuesday, May 8 Earnings List: HSIC, PEN & More
Article By: Zacks Investment Research Tuesday, May 8, 2018 5:47 AM EDT
The Medical sector has put up a stellar show so far. It is projected to rise 13.6% on 8.3% revenue growth this earnings season.
In this article: BIO, HAE, HSIC, PEN
Read
E Medical Tech M&A Analysis: Neuro, Orthopedic, Aesthetics And Specialty
Article By: Joe Kunkle Wednesday, June 8, 2016 7:04 AM EDT
In the final part of my series looking at Med-Tech M&A landscape I focus on a diverse group of names, and come to find XENT is the most compelling.
In this article: HAE, CYNO, CNMD, IART, WMGI, ZLTQ, XENT, ENTL, PEN, NVRO Also: LDRH, ZBH
Read
Short Opportunity For Penumbra Following Expiration Of Earnings Blackout Period
Article By: Don Dion Monday, April 25, 2016 2:35 PM EDT
With just 4M shares initially offered to the public, if even a few insiders sell, it could send PEN's stock price tumbling down. We suggest shorting PEN prior to the end of the blackout period to take advantage of the likely price decline.
In this article: PEN Also: BSX, JNJ, MDT, SYK
Read
Penumbra: Impending Lockup Expiration And Short Opportunity
Article By: Don Dion Friday, March 4, 2016 1:01 PM EDT
March 16, 2016 concludes the 180-day lockup period on PEN. At this point, an array of powerful insiders will have a first chance to reap profits since PEN went public mid-September.
In this article: PEN
Read
IPO Quiet Period Expiration - Penumbra
Article By: Don Dion Sunday, October 11, 2015 5:03 AM EDT
PEN's share prices will likely see a temporary rise in response to the release of the underwriter reports, opening another buying opportunity for this growing firm.
In this article: PEN Also: JNJ, SYK, BSX, MDT
Read
Penumbra IPO Preliminary Points
Article By: IPO Candy Monday, September 14, 2015 7:40 PM EDT
This is an IPO to watch, and probably own. Being able to effectively treat stroke victims is a big deal.
In this article: PEN Also: BSX, MDT, JNJ, SYK
Read
1 to 8 of 8 Posts